Summary The coronavirus disease 2019 (COVID‐19) pandemic is a rapidly evolving global
emergency that continues to strain healthcare systems. Emerging research describes a …

Background The clinical significance of cardiac troponin measurement in patients
hospitalised for coronavirus disease 2019 (covid-19) is uncertain. We investigated the …

Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 and was first reported in December 2019 in Wuhan, China. Since …

Objective Predictive value of myocardial injury as defined by elevated cardiac tropnins
(cTns) in patients with COVID-19 has not been fully investigated. We performed a meta …

Objectives Several studies have demonstrated an association between elevated cardiac
biomarkers and adverse outcomes in patients with COVID-19. However, the prognostic and …

Background and aims Myocardial injury defined by elevation of cardiac troponins (cTn) in
the course of coronavirus disease 2019 (COVID-19) pandemic has been reported, though …

Background: For coronavirus disease 2019 (COVID-19), early identification of patients with
serious symptoms at risk of critical illness and death is important for personalized treatment …

ST-segment elevation myocardial infarction (STEMI) complicating COVID-19 is associated
with an increased risk of cardiogenic shock and mortality. However, little is known about the …

Background: The aim of this study was to determine the magnitude of abnormal organ
function tests and biomarkers in hospitalized patients with confirmed COVID-19 and to …

Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection is causing a dramatic pandemic, affecting 12,847,293 …